Results 41 to 50 of about 58,111 (236)

Impact of a Pharmacist-Provided Spirometry Service on Access to Results in a Primary Care Setting

Journal of Primary Care & Community Health, 2018
Objectives: The primary objective of this study was to determine the effect of a pharmacist-provided spirometry service within a federally qualified health center on the percentage of spirometry referrals completed with results reviewed by the ordering ...
Lisa A. Mueller, Alexa Sevin Valentino, Aaron D. Clark, Junan Li   +3 more
doaj   +1 more source

Long‐term impact of Elexacaftor/Tezacaftor/ivacaftor on pulmonary, nutritional and metabolic outcomes in homozygous F508del cystic fibrosis patients: A real‐world cohort study

British Journal of Clinical Pharmacology, EarlyView.
Aim Elexacaftor/tezacaftor/ivacaftor (ETI) has markedly improved cystic fibrosis (CF) outcomes. However, its long‐term impact on nutrition, metabolism and liver health remains underexplored. We assessed 30‐month changes in pulmonary, nutritional, metabolic and inflammatory markers in people with CF (PwCF) homozygous for F508del.
Nicola Perrotta, Luigi Angelo Fiorito, Roberta Vescovo, Anna Virgilio, Giulia Amato, Giuseppe Cimino   +5 more
wiley   +1 more source

Spirometry reference equations for central European populations from school age to old age. [PDF]

PLoS ONE, 2013
BackgroundSpirometry reference values are important for the interpretation of spirometry results. Reference values should be updated regularly, derived from a population as similar to the population for which they are to be used and span across all ages.
Mascha K Rochat, Ruediger P Laubender, Daniela Kuster, Otto Braendli, Alexander Moeller, Ulrich Mansmann, Erika von Mutius, Johannes Wildhaber   +7 more
doaj   +1 more source

Pharmacist-Driven Spirometry Screening to Target High-Risk Patients in a Primary Care Setting

Journal of Primary Care & Community Health, 2019
Objectives: The primary objective of this study is to determine the effect of proactive pharmacist identification of high-risk patients eligible for diagnostic spirometry testing on the percentage of appropriate spirometry referrals ordered and the ...
Jangus B. Whitner, Lisa A. Mueller, Alexa Sevin Valentino   +2 more
doaj   +1 more source

Race-specific spirometry equations may overestimate asthma control in Black children and adolescents

Respiratory Research, 2023
Background A growing body of evidence suggests that use of race terms in spirometry reference equations underestimates disease burden in Black populations, which may lead to disparities in pulmonary disease outcomes.
Allison J. Burbank, Claire E. Atkinson, Andre E. Espaillat, Stephen A. Schworer, Katherine Mills, Jennifer Rooney, Ceila E. Loughlin, Wanda Phipatanakul, Michelle L. Hernandez   +8 more
doaj   +1 more source

Digital diagnostics, biomarkers and therapeutics in an evolving healthcare system: From promise to practice

British Journal of Clinical Pharmacology, EarlyView.
Abstract Health care is shifting towards a digital‐guided system, integrating digital diagnostics, biomarkers and therapeutics in many care pathways. However, despite rapid technological advancement and preliminary adoption accelerated by the COVID‐19 pandemic, a significant implementation gap persists. This narrative review explores the causes of this
Mees H. P. Stoop, Gertjan J. A. Driessen, Adam F. Cohen, Matthijs D. Kruizinga   +3 more
wiley   +1 more source

Spirometry use: detection of chronic obstructive pulmonary disease in the primary care setting

Clinical Interventions in Aging, 2011
Thomas A Barnes1, Len Fromer21Department of Cardiopulmonary Sciences, Northeastern University, Boston, MA, USA; 2David Geffen School of Medicine at UCLA, Los Angeles, CA, USAObjective: To describe a practical method for family practitioners to stage ...
Thomas A Barnes, Len Fromer
doaj  

A phase 1 evaluation of inhaled oxytocin: Physiologically‐based pharmacokinetic model informed dosing of a novel heat‐stable oxytocin delivery system

British Journal of Clinical Pharmacology, EarlyView.
Aim To develop and validate a physiologically‐based pharmacokinetic (PBPK) model enabling inhaled oxytocin dose selection for clinical evaluation. Subsequently, to conduct a phase 1 study investigating the pharmacokinetics and safety of selected doses of an optimized inhaled oxytocin product in healthy, non‐pregnant female participants.
Pete Lambert, Carl M. J. Kirkpatrick, Rory Marriott, Siladitya Ray Chaudhuri, David Polidori, Bart Remmerie, Michelle P. McIntosh   +6 more
wiley   +1 more source

Home Spirometry for Post-COVID Recovery: A Clinical Validation Study of an Ultrasonic Device

Diagnostics
Background/Objectives: Patients recovering from COVID-19 often experience persistent respiratory symptoms, necessitating pulmonary function monitoring. While clinical spirometry is the gold standard, home spirometry offers a remote alternative.
Asli Gorek Dilektasli, Ayten Odabas, Ismet Polat, Abdurrahman Dogan, Guven Ozkaya, Ozge Aydin Guclu, Nilufer Aylin Acet Ozturk, Funda Coskun, Mehmet Karadag   +8 more
doaj   +1 more source

Association of COPD with adverse outcomes in heart failure patients with preserved ejection fraction

ESC Heart Failure, Volume 12, Issue 2, Page 799-808, April 2025.
Abstract We performed a systematic review and meta‐analysis to detect the impact of chronic obstructive pulmonary disease (COPD) on the prognosis of heart failure patients with preserved ejection fraction (HFpEF). We systematically screened eligible literature from three electronic databases, PubMed, EMBASE and Cochrane Library, up to April 2023.
Shuo Xu, Zhenbang Gu, Wengen Zhu, Shenghui Feng   +3 more
wiley   +1 more source